Tag Archives: nicotinic acid
March 2013 Br J Cardiol 2013;20:16-17
In brief – cardiology news roundup
BJCardio Staff
New editorial board member Dr Ketan Dhatariya We are delighted to welcome Dr Ketan Dhatariya to our editorial board. Dr Dhatariya is a consultant in diabetes, endocrinology and general medicine at Norfolk and Norwich University Hospital, Norwich. He is also a senior lecturer at the University of East Anglia, and an assistant professor of medicine at St George’s University, Grenada, in the West Indies. He has published on a wide variety of diabetes- and endocrine-related subjects, including diabetes-related foot disease. He serves as meetings secretary for the Association of British Clinical Diabetologists, and medical secretary for the Spec
September 2009 Br J Cardiol 2009;16:226
In brief
BJCardio editorial staff
Nicotinic acid/laropiprant combination launched in UK A combination of nicotinic acid and laropiprant (Tredaptive®), for the treatment of dyslipidaemia (particularly combined mixed dyslipidaemia and primary hypercholesterolaemia) has been launched in the UK by Merck Sharp & Dohme. It should be used in combination with statins when the cholesterol-lowering effect of statin monotherapy is inadequate, and as monotherapy only if statins are thought inappropriate or if they are not tolerated. Diet and other non-pharmacological measures to control lipid levels should be continued. It is hoped that the addition of the anti-flushing agent laropi
November 2006 Br J Cardiol 2006;13:411-8
Cost-effectiveness of adding prolonged-release nicotinic acid in statin-treated patients who achieve LDL cholesterol goals but remain at risk due to low HDL cholesterol: a UK-based economic evaluation
BJCardio editorial team
No content available
July 2006 Br J Cardiol 2006;13:273-7
Safety and tolerability of prolonged-release nicotinic acid combined with a statin in NAUTILUS
Anja Vogt, Ursula Kassner, Ulrike Hostalek, Elisabeth Steinhagen-Thiessen, on behalf of the NAUTILUS Study Group
No content available
March 2006 Br J Cardiol 2006;13:131-6
The failure of LDL cholesterol reduction and the importance of reverse cholesterol transport. The role of nicotinic acid
H Robert Superko
No content available
March 2005 Br J Cardiol 2005;12:118-22
Dyslipidaemia in ethnic populations: special considerations
Anthony H Barnett
No content available
November 2003 Br J Cardiol 2003;10:462-8
Modified-release nicotinic acid for dyslipidaemia: novel formulation improves tolerability and optimises efficacy
Michael Schachter
No content available
For healthcare professionals only
